Tormere Analytics
OverviewStock ResearchChartsPortfolio LabOptions LabCalculatorsWatchlist
Data Explorer
Articles
Pricing
Privacy PolicyTerms of Service

HIMS

$29.00-1.02%website ↗⬇ financials (.py)

Hims & Hers Health, Inc.

Market Cap
$6.7B
Live price × shares (2026-09-17)
Sector
Health Care
Industry
Health Care
Beta (raw)
2.41
60mo monthly vs SPY
P/E (TTM)
N/M
Price / TTM net income
P/S (TTM)
2.6
Price / TTM revenue
P/B
20.7
Price / stockholders equity
EV/EBITDA
—
TTM
Price Chart
Loading…

Signals

Insider Velocity
4.9x
selling
Congress
1
recent trades
Short Volume
60%
W/W -2.1pp

Market & Alt Data

News
15
recent articles
Activist
13D
Dudum
Analyst Consensus
Sell
22 analysts
Velocity Score
4.90x
Sell Rate (90d)
1658.47/mo
Sell Baseline
916.38/mo
Unique Sellers (90d)
5
Sort by
Type
Trade DateFiledOwnerRoleTypeSharesPriceValueOwned After
2026-10-012026-10-02Okupe OluyemiChief Financial OfficerSale2,000$29.70$59K234.5KView
2026-09-302026-10-02Boughton SoleilChief Legal OfficerSale3,461$29.17$101K300.8KView
2026-09-222026-09-23Okupe OluyemiChief Financial OfficerSale29.3K$29.95$877K236.5KView
2026-09-172026-09-18Okupe OluyemiChief Financial OfficerSale12.3K$28.82$355K251.8KView
2026-09-162026-09-17Boughton SoleilChief Legal OfficerSale6,236$27.86$174K304.3KView
1–5 of 34
1 / 7

Reporting Insiders

  • Oluyemi Okupe
    Chief Financial Officer
    8 transactions · last 2026-10-01
  • Soleil Boughton
    Chief Legal Officer
    4 transactions · last 2026-09-30
  • Michael Chi
    Chief Operating Officer
    1 transaction · last 2026-09-15
  • Mohamed Elshenawy
    CTO
    1 transaction · last 2026-09-15
  • Deborah M. Autor
    Director & Chief Policy Officer
    1 transaction · last 2026-08-18
  • Oluyemi Okupe
    Chief Financial Officer
    7 transactions · last 2026-06-22
  • Patrick Harrison Carroll
    Chief Medical Officer
    1 transaction · last 2026-06-18

Recent News

HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish
Stocktwits · 2026-10-04
HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’
Stocktwits · 2026-10-04
Is New Regional CMOs Altering The Investment Case For Hims & Hers Stock (HIMS)?
Simply Wall Street · 2026-10-03
Robinhood’s Tokenized Stocks Are Becoming a New Memecoin Trade: Report
Yahoo · 2026-10-02
Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade
Yahoo · 2026-10-01
Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS
PR Newswire · 2026-10-01
Hims & Hers Names Chief Medical Officers in the UK and Australia, Deepening its Investment in Local Clinical Leadership
Yahoo · 2026-10-01
Hims & Hers Goes Global - Renewed Growth Prospects With Margin Risks (NYSE:HIMS)
Seeking Alpha · 2026-10-01
Hims & Hers Goes Global - Renewed Growth Prospects With Margin Risks
SeekingAlpha · 2026-09-30
10 Health Care Stocks With Whale Alerts In Today’s Session
Benzinga · 2026-09-30
HIMS & HERS HEALTH, INC. (HIMS) SHAREHOLDER ALERT Bernstein
GlobeNewswire · 2026-09-30
Hims & Hers: U.S. Revenue Reacceleration Is Reassuring, And Valuation Compression Is Compelling (Upgrade)
SeekingAlpha · 2026-09-30
Hims & Hers Stock: 30% Growth Can’t Hide a Margin Problem
Yahoo · 2026-09-28
Signal: Fintech Firm Fit to Resume Run Higher
Yahoo · 2026-09-28
Can Hims & Hers Health (HIMS) Stay Cheap As Sales Face Scrutiny?
Yahoo · 2026-09-27

Informational purposes only, not investment advice.

Hims & Hers Health, Inc. (HIMS)

tormere.com/research/HIMS · generated 2026-10-05

$29.00
-1.02%
General Information
Price$29.00
Change-1.02%
Market Cap$6.7B
SectorHealth Care
IndustryHealth Care
ExchangeNYSE
Beta (raw, 60mo vs SPY)2.41
Signals
Insider Velocity4.9x selling
Congress Trades1
  • Michael Chi
    Chief Operating Officer
    2 transactions · last 2026-06-17
  • Irene Becklund
    PAO
    3 transactions · last 2026-06-17
  • Mohamed Elshenawy
    CTO
    1 transaction · last 2026-06-17
  • David B. Wells
    Director
    1 transaction · last 2026-05-26
  • Soleil Boughton
    Chief Legal Officer
    3 transactions · last 2026-04-20
    • Short Volume
    60% of daily vol
    Conviction Score24/100
    Analyst ConsensusSB 2 · B 7 · H 13 · S 0 · SS 0
    Price Chart (1 Year)
    2025-10-062026-10-02$62.76$14.52
    Recent Insider Activity (Form 4) — Last 5
    DateInsiderTypeSharesValue
    2026-10-01Okupe OluyemiS2,000$59,400
    2026-09-30Boughton SoleilS3,461$100,957.37
    2026-09-22Okupe OluyemiS29,277$876,846.15
    2026-09-17Okupe OluyemiS12,313$354,860.66
    2026-09-16Boughton SoleilS6,236$173,734.96
    Congressional Trades — Last 5
    DateMemberChamberTypeAmount
    2025-08-04Lisa McClainhousePurchase$1,001 - $15,000
    Recent News
    • HIMS Stock Hits 2026 High After Unlocking $400M Working Capital Through JPMorgan — Retail Gets Less Bearish — Stocktwits · 2026-10-04
    • HIMS Stock Slips Overnight After FDA Staff Questions Safety Of Popular Peptides — But One Analyst Says ‘This Isn’t The End’ — Stocktwits · 2026-10-04
    • Is New Regional CMOs Altering The Investment Case For Hims & Hers Stock (HIMS)? — Simply Wall Street · 2026-10-03
    • Robinhood’s Tokenized Stocks Are Becoming a New Memecoin Trade: Report — Yahoo · 2026-10-02
    • Hims & Hers Health, Inc. (HIMS) Stock Slides as Market Rises: Facts to Know Before You Trade — Yahoo · 2026-10-01

    Tormere — informational purposes only, not investment advice.

    Factor Profile

    Pro
    Pro feature

    Fama-French factor analysis is available on the Pro plan.

    Upgrade to Pro →